Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy, France
NCT Number: NCT03336177
Systematic screening for cervical cancer stops in France at 65 years old. The incidence of certain types of gynecological neoplasia increases with age (endometrium, vulva). Diagnosis delay of 8 months has been described for uterine cancer and longer delays for vulvar cancer.
The aim of our study is to understand help-seeking behavior and its delay for this type of cancer among patients older than 65.
Looking for future studies?
Notify Me65 year and older
Female
Observational
Vandœuvre-lès-Nancy, France
Our study assess the reasons for which the patient took time to go to the doctor despite of their symptoms. We use a qualitative methodology. Our study categorizes lived experiences, recorded in semistructured interview transcripts. We use psychodynamic and semiopragmatic analyses of the discourse to obtain hypotheses about possible reasons of the delay in the help-seeking process."
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be interviewed by open-ended questions face to face concerning their past experiences. The recorded interview will be transcribed and analyzed by psychodynamic and semio-pragmatic approach.
Time frame: 1 day
Qualitative interview performed at one occasion where the patient describes the experience of the help seeking period she has passed through.
Time frame: 1 day
qualitative methodology using verbal data analysis of semi-structured interview.
Institut de Cancérologie de Lorraine
Other
Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. Qualitative Approach
Acronym: CODEGY65
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04534075
Adnexal Diseases, Anus Diseases
Gothenburg, Sweden
View Trial DetailsNCT06168825
Acceptance and Commitment Therapy, Blood Cancer
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05131815
Astrocytoma, Behavior
Los Angeles, California, United States
View Trial DetailsNCT04604158
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial Details